Endovascular Venous Interventions - A State-of-the-Art Review

Curr Probl Cardiol. 2023 Mar;48(3):101534. doi: 10.1016/j.cpcardiol.2022.101534. Epub 2022 Dec 6.

Abstract

Venous vascular diseases are an important clinical entity estimated to affect several million people worldwide. Deep vein thrombosis (DVT) is a common venous disease with a population variable prevalence of 122 to 160 persons per 100,000 per year, whereas pulmonary embolism (PE) affects up to 60 to 70 per 100 000 and carries much higher mortality. Chronic venous diseases, which cause symptoms like leg swelling, heaviness, pain, and discomfort, are most prevalent in the elderly and significantly impact their quality of life. Some estimate that chronic vascular diseases account for up to 2% of healthcare budgets in Western countries. Treating venous vascular disease includes using systemic anticoagulation and interventional therapies in some patient subsets. In this comprehensive review, we discuss endovascular treatment modalities in the management of venous vascular diseases.

Publication types

  • Review

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use
  • Humans
  • Pulmonary Embolism* / drug therapy
  • Pulmonary Embolism* / therapy
  • Quality of Life
  • Risk Factors
  • Thrombolytic Therapy
  • Venous Thrombosis* / epidemiology
  • Venous Thrombosis* / etiology
  • Venous Thrombosis* / therapy

Substances

  • Anticoagulants